These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
87 related articles for article (PubMed ID: 18336404)
1. Ten years of "Optimal Therapy in Advanced Ovarian Cancer. Update" meeting. Poveda A Int J Gynecol Cancer; 2008; 18 Suppl 1():67-70. PubMed ID: 18336404 [TBL] [Abstract][Full Text] [Related]
2. GEICO (Spanish Group for Investigation on Ovarian Cancer) treatment guidelines in ovarian cancer 2012. González Martín A; Redondo A; Jurado M; De Juan A; Romero I; Bover I; Del Campo JM; Cervantes A; García Y; López-Guerrero JA; Mendiola C; Palacios J; Rubio MJ; Poveda Velasco A Clin Transl Oncol; 2013 Jul; 15(7):509-25. PubMed ID: 23468275 [TBL] [Abstract][Full Text] [Related]
3. Gynecologic Oncology Group (GOG-USA) trials in ovarian cancer. Ozols RF Adv Exp Med Biol; 2008; 622():131-43. PubMed ID: 18546624 [No Abstract] [Full Text] [Related]
4. The 5th Shanghai Gynecologic Oncology Group (SGOG)-Korean Gynecologic Oncology Group (KGOG) joint meeting and 2016 Asia-Pacific Ovarian cancer Laparotomy and Laparoscopic Operation (APOLLO) symposium in Shanghai. Chang HK; Kim BG; Shi TY; Zang R J Gynecol Oncol; 2016 Nov; 27(6):e64. PubMed ID: 27775260 [No Abstract] [Full Text] [Related]
5. The global impact of the Gynecologic Cancer InterGroup in enhancing clinical trials in ovarian cancer. Bacon M; Kitchener H; Stuart GC; Vermorken JB; Int J Gynecol Cancer; 2011 May; 21(4):746-9. PubMed ID: 21543935 [TBL] [Abstract][Full Text] [Related]
6. Ovarian cancer: is the news good enough? Poveda A Int J Gynecol Cancer; 2005; 15 Suppl 3():298-306. PubMed ID: 16343247 [TBL] [Abstract][Full Text] [Related]
7. Evolution of the Gynecologic Oncology Group protocols in the treatment of epithelial ovarian cancer. Seamon LG; Richardson DL; Copeland LJ Clin Obstet Gynecol; 2012 Mar; 55(1):131-55. PubMed ID: 22343234 [TBL] [Abstract][Full Text] [Related]
8. 2004 consensus statements on the management of ovarian cancer: final document of the 3rd International Gynecologic Cancer Intergroup Ovarian Cancer Consensus Conference (GCIG OCCC 2004). du Bois A; Quinn M; Thigpen T; Vermorken J; Avall-Lundqvist E; Bookman M; Bowtell D; Brady M; Casado A; Cervantes A; Eisenhauer E; Friedlaender M; Fujiwara K; Grenman S; Guastalla JP; Harper P; Hogberg T; Kaye S; Kitchener H; Kristensen G; Mannel R; Meier W; Miller B; Neijt JP; Oza A; Ozols R; Parmar M; Pecorelli S; Pfisterer J; Poveda A; Provencher D; Pujade-Lauraine E; Randall M; Rochon J; Rustin G; Sagae S; Stehman F; Stuart G; Trimble E; Vasey P; Vergote I; Verheijen R; Wagner U; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; Ann Oncol; 2005; 16 Suppl 8():viii7-viii12. PubMed ID: 16239238 [No Abstract] [Full Text] [Related]
9. Malignant transformation within ovarian dermoid cysts: an audit of treatment received and patient outcomes. an Australia New Zealand gynaecological oncology group (ANZGOG) and gynaecologic cancer intergroup (GCIG) study. Gainford MC; Tinker A; Carter J; Petru E; Nicklin J; Quinn M; Hammond I; Elit L; Lenhard M; Friedlander M Int J Gynecol Cancer; 2010 Jan; 20(1):75-81. PubMed ID: 20130506 [TBL] [Abstract][Full Text] [Related]
10. How Can We Improve Education of Breast Surgeons Across Europe? Kolacinska A Chirurgia (Bucur); 2017; 112(4):365-366. PubMed ID: 28862111 [TBL] [Abstract][Full Text] [Related]
11. Gynecologic Cancer InterGroup (GCIG) consensus review for ovarian tumors of low malignant potential (borderline ovarian tumors). Harter P; Gershenson D; Lhomme C; Lecuru F; Ledermann J; Provencher DM; Mezzanzanica D; Quinn M; Maenpaa J; Kim JW; Mahner S; Hilpert F; Baumann K; Pfisterer J; du Bois A Int J Gynecol Cancer; 2014 Nov; 24(9 Suppl 3):S5-8. PubMed ID: 25341581 [TBL] [Abstract][Full Text] [Related]
12. ICON 2 and ICON 3 data in previously untreated ovarian cancer: results to date. Harper P Semin Oncol; 1997 Oct; 24(5 Suppl 15):S15-23-S15-25. PubMed ID: 9346217 [TBL] [Abstract][Full Text] [Related]
14. Medical therapy of advanced malignant epithelial tumours of the ovary. Colombo N; Parma G; Bocciolone L; Franchi D; Sideri M; Maggioni A Forum (Genova); 2000; 10(4):323-32. PubMed ID: 11535983 [TBL] [Abstract][Full Text] [Related]
15. Clinical trials in recurrent ovarian cancer. Friedlander M; Trimble E; Tinker A; Alberts D; Avall-Lundqvist E; Brady M; Harter P; Pignata S; Pujade-Lauraine E; Sehouli J; Vergote I; Beale P; Bekkers R; Calvert P; Copeland L; Glasspool R; Gonzalez-Martin A; Katsaros D; Kim JW; Miller B; Provencher D; Rubinstein L; Atri M; Zeimet A; Bacon M; Kitchener H; Stuart GC; Int J Gynecol Cancer; 2011 May; 21(4):771-5. PubMed ID: 21543939 [TBL] [Abstract][Full Text] [Related]
16. Research Summaries: The 11th Biennial Rivkin Center Ovarian Cancer Research Symposium. Armstrong DK Int J Gynecol Cancer; 2017 Nov; 27(9S Suppl 5):S1. PubMed ID: 29278598 [TBL] [Abstract][Full Text] [Related]
17. 2010 Gynecologic Cancer InterGroup (GCIG) consensus statement on clinical trials in ovarian cancer: report from the Fourth Ovarian Cancer Consensus Conference. Stuart GC; Kitchener H; Bacon M; duBois A; Friedlander M; Ledermann J; Marth C; Thigpen T; Trimble E; ; Int J Gynecol Cancer; 2011 May; 21(4):750-5. PubMed ID: 21543936 [TBL] [Abstract][Full Text] [Related]
18. [Up-date on cytoreductive surgery in the management of advanced ovarian cancer]. Angioli R; Palaia I; Damiani P; Montera R; Benedetti Panici P Minerva Ginecol; 2006 Dec; 58(6):459-70. PubMed ID: 17108876 [TBL] [Abstract][Full Text] [Related]
19. Gynecologic Cancer InterGroup (GCIG) consensus review for squamous cell carcinoma of the ovary. Glasspool RM; González Martín A; Millan D; Lorusso D; Åvall-Lundqvist E; Hurteau JA; Davis A; Hilpert F; Kim JW; Alexandre J; Ledermann JA Int J Gynecol Cancer; 2014 Nov; 24(9 Suppl 3):S26-9. PubMed ID: 25126954 [TBL] [Abstract][Full Text] [Related]